Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Menter

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
Journal of the American Academy of Dermatology|October 16, 2007
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialAlan Menter, Stephen K Tyring, Kenneth Gordon, et al.
Cutis|October 2, 2002
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksJonathan Weiss, Alan Menter, Oscar Hevia, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital PsoriasisJoseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
JAMA Dermatology|August 25, 2016
Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 DiabetesBobbak Mansouri, Dario Kivelevitch, Balaji Natarajan, et al.
Journal of Medical Economics|June 5, 2019
Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)Louis S Matza, John E Brazier, Katie D Stewart, et al.
The New England Journal of Medicine|March 30, 2012
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasisKim A Papp, Craig Leonardi, Alan Menter, et al.
Journal of the American Academy of Dermatology|January 30, 2013
OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasisAlexa B Kimball, David Pariser, Paul S Yamauchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporterAlan Menter, Breck Thrash, Christina Cherian, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.
Journal of the American Academy of Dermatology|August 12, 2015
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS studyIan Landells, Colleen Marano, Ming-Chun Hsu, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
Journal of the American Academy of Dermatology|October 16, 2007
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialAlan Menter, Stephen K Tyring, Kenneth Gordon, et al.
Cutis|October 2, 2002
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksJonathan Weiss, Alan Menter, Oscar Hevia, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2017
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital PsoriasisJoseph F Merola, Alison Potts Bleakman, Alice B Gottlieb, et al.
JAMA Dermatology|August 25, 2016
Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 DiabetesBobbak Mansouri, Dario Kivelevitch, Balaji Natarajan, et al.
Journal of Medical Economics|June 5, 2019
Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)Louis S Matza, John E Brazier, Katie D Stewart, et al.
The New England Journal of Medicine|March 30, 2012
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasisKim A Papp, Craig Leonardi, Alan Menter, et al.
Journal of the American Academy of Dermatology|January 30, 2013
OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasisAlexa B Kimball, David Pariser, Paul S Yamauchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporterAlan Menter, Breck Thrash, Christina Cherian, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.
Journal of the American Academy of Dermatology|August 12, 2015
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS studyIan Landells, Colleen Marano, Ming-Chun Hsu, et al.
Pageof 30